SCHEMBL5095441

SCHEMBL5095441

COc1cc(S(=O)(=O)c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.59
TSHR P16473 1/20 0.59
MAPK1 P28482 1/20 0.59
ACHE P22303 1/20 0.52
CA9 Q16790 3/20 0.52
CA12 O43570 2/20 0.52
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
LOXL2 Q9Y4K0 2/20 0.51
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
EGFR P00533 1/20 0.47
PTGS2 P35354 2/20 0.46
KDM4E B2RXH2 2/20 0.46
GAA P10253 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
USP2 O75604 1/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319937 0.84 SMN1; SMN2 (0.52) POLBTSHRMAPK1ACHECA9
SCHEMBL2217165 0.82 CYP3A4 (0.52) POLBTSHRMAPK1ACHECA9
SCHEMBL7246613 0.82 CA9 (0.49) POLBTSHRMAPK1ACHECA9
SCHEMBL7319931 0.82 CA9 (0.49) POLBTSHRMAPK1ACHECA9
SCHEMBL4005582 0.82 CA9 (0.68) ACHECA9CA12CA1CA2
SCHEMBL2368094 0.82 CA9 (0.49) POLBTSHRMAPK1ACHECA9
SCHEMBL725276 0.80 EGFR (0.55) POLBTSHRMAPK1CA9CA12
SCHEMBL5982255 0.79 POLB (0.57) POLBTSHRMAPK1CA9CA12
SCHEMBL9490711 0.79 POLB (0.57) POLBTSHRMAPK1CA9CA12
SCHEMBL9112719 0.77 CA9 (0.45) POLBTSHRMAPK1ACHECA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410998-B2 Inhibitors of NADH:ubiquinone oxidoreductase THE SCRIPPS RESEARCH INSTITUTE (US) 2008-08-12 US disclosed
US-20040034239-A1 Inhibitors of nadh:ubiquinone oxidoreductase NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-02-19 US disclosed
WO-2002020008-A1 INHIBITORS OF NADH:UBIQUINONE OXIDOREDUCTASE THE SCRIPPS RESEARCH INSTITUTE (US) 2002-03-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034239-A1 Inhibitors of nadh:ubiquinone oxidoreductase NQO1, NDUFV1, NDUFV2 POLB 547/4885TSHR 4756/4885MAPK1 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.